Edition:
United Kingdom

Julie Steenhuysen

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

12 Jan 2018

Flu in U.S. now widespread but season may be peaking: CDC

CHICAGO Seasonal influenza is now widespread across the continental United States, causing severe illness and rising numbers of hospitalizations, but this year's outbreak may be peaking, government health officials said on Friday.

21 Dec 2017

Opioid crisis trims U.S. life expectancy, boosts hepatitis C: CDC

CHICAGO The opioid crisis is rippling through the U.S. healthcare system, causing a spike in rates of hepatitis C related to increased opioid injections and reducing overall life expectancy among Americans, which has fallen for the second year in a row, U.S. health officials said on Thursday.

19 Dec 2017

U.S. lifts funding ban on studies that enhance dangerous germs

CHICAGO The U.S. government on Tuesday lifted a 2014 temporary ban on funding research involving the flu and other pathogens in which scientists deliberately make them more transmissible or more deadly.

19 Dec 2017

U.S. lifts funding ban on studies that enhance dangerous germs

CHICAGO The U.S. government on Tuesday lifted a 2014 temporary ban on funding research involving the flu and other pathogens in which scientists deliberately make them more transmissible or more deadly.

14 Dec 2017

Seasonal flu kills more globally than previously thought: U.S. study

CHICAGO As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.

13 Dec 2017

U.S. study sheds light on how Zika causes nerve disorder

CHICAGO A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.

13 Dec 2017

Did Sanofi, WHO ignore warning signals on dengue vaccine?

CHICAGO/LONDON When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease.

05 Dec 2017

Trial results of Zika vaccine Sanofi dropped show promise

CHICAGO A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday.

30 Nov 2017

Foundation's cancer gene test gets U.S. FDA and Medicare nod

CHICAGO A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said.

30 Nov 2017

Nanotech, gene editing used to edit cholesterol gene-US study

(This story corrects first paragraph in Nov. 13 story to show the study also included Russian researchers.)

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,755.93 -13.21 -0.17%
DAX 13,246.33 + 45.82 +0.35%
CAC 40 5,513.82 + 4.13 +0.07%
TR Europe 196.22 + 0.12 +0.06%
GBP/USD 1.3815 +0.17%
GBP/EUR 1.1242 -0.04%
EUR/USD 1.2287 +0.23%
Gold 1,335.40 +0.00 +0.00%
Oil 63.90 +0.17 +0.27%
Corn 348.75 +0.50 +0.14%